List of MeSH codes (C18)

The following is a partial list of the “C” codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM).

This list continues the information at List of MeSH codes (C17). Codes following these are found at List of MeSH codes (C19). For other MeSH codes, see List of MeSH codes.

The source for this content is the set of 2006 MeSH Trees from the NLM.

Table of Contents

after-content-x4

MeSH C18.452 – metabolic diseases[edit]

MeSH C18.452.076 – acid-base imbalance[edit]

MeSH C18.452.090 – amyloidosis[edit]

MeSH C18.452.100 – brain diseases, metabolic[edit]

MeSH C18.452.174 – calcium metabolism disorders[edit]

MeSH C18.452.284 – DNA repair-deficiency disorders[edit]

MeSH C18.452.339 – dyslipidemias[edit]

MeSH C18.452.394 – glucose metabolism disorders[edit]

MeSH C18.452.413 – hyperammonemia[edit]

MeSH C18.452.421 – hyperamylasemia[edit]

MeSH C18.452.429 – hyperbilirubinemia[edit]

MeSH C18.452.497 – hyperoxaluria[edit]

MeSH C18.452.500 – hyperprolactinemia[edit]

MeSH C18.452.506 – hyperuricemia[edit]

MeSH C18.452.512 – hypervitaminosis A[edit]

MeSH C18.452.565 – iron metabolism disorders[edit]

MeSH C18.452.603 – malabsorption syndromes[edit]

MeSH C18.452.625 – metabolic syndrome x[edit]

MeSH C18.452.648 – metabolism, inborn errors[edit]

MeSH C18.452.648.066 – amino acid metabolism, inborn errors
MeSH C18.452.648.066.102 – albinism
MeSH C18.452.648.066.102.090 – albinism, ocular
MeSH C18.452.648.066.102.100 – albinism, oculocutaneous
MeSH C18.452.648.066.102.100.400 – Hermansky–Pudlak syndrome
MeSH C18.452.648.066.102.600 – piebaldism
MeSH C18.452.648.066.187 – alkaptonuria
MeSH C18.452.648.066.210 – aminoaciduria, renal
MeSH C18.452.648.066.210.250 – cystinuria
MeSH C18.452.648.066.210.490 – Hartnup disease
MeSH C18.452.648.066.275 – carbamoyl phosphate synthase I deficiency disease
MeSH C18.452.648.066.340 – citrullinemia
MeSH C18.452.648.066.470 – homocystinuria
MeSH C18.452.648.066.475 – hyperargininemia
MeSH C18.452.648.066.477 – hyperglycinemia, nonketotic
MeSH C18.452.648.066.480 – hyperhomocysteinemia
MeSH C18.452.648.066.544 – hyperlysinemias
MeSH C18.452.648.066.608 – maple syrup urine disease
MeSH C18.452.648.066.620 – multiple carboxylase deficiency
MeSH C18.452.648.066.620.100 – biotinidase deficiency
MeSH C18.452.648.066.620.380 – holocarboxylase synthetase deficiency
MeSH C18.452.648.066.729 – ornithine carbamoyltransferase deficiency disease
MeSH C18.452.648.066.766 – phenylketonurias
MeSH C18.452.648.066.766.500 – phenylketonuria, maternal
MeSH C18.452.648.066.880 – tyrosinemias
MeSH C18.452.648.088 – amino acid transport disorders, inborn
MeSH C18.452.648.088.400 – hartnup disease
MeSH C18.452.648.088.600 – oculocerebrorenal syndrome
MeSH C18.452.648.100 – amyloidosis, familial
MeSH C18.452.648.100.050 – amyloid neuropathies, familial
MeSH C18.452.648.100.160 – cerebral amyloid angiopathy, familial
MeSH C18.452.648.151 – brain diseases, metabolic, inborn
MeSH C18.452.648.151.050 – abetalipoproteinemia
MeSH C18.452.648.151.162 – carbamoyl-phosphate synthase i deficiency disease
MeSH C18.452.648.151.168 – cerebral amyloid angiopathy, familial
MeSH C18.452.648.151.175 – citrullinemia
MeSH C18.452.648.151.300 – fucosidosis
MeSH C18.452.648.151.320 – galactosemias
MeSH C18.452.648.151.330 – glycogen storage disease type II
MeSH C18.452.648.151.355 – hartnup disease
MeSH C18.452.648.151.360 – hepatolenticular degeneration
MeSH C18.452.648.151.365 – homocystinuria
MeSH C18.452.648.151.370 – hyperargininemia
MeSH C18.452.648.151.375 – hyperglycinemia, nonketotic
MeSH C18.452.648.151.380 – hyperlysinemias
MeSH C18.452.648.151.412 – Leigh disease
MeSH C18.452.648.151.425 – Lesch–Nyhan syndrome
MeSH C18.452.648.151.435 – lysosomal storage diseases, nervous system
MeSH C18.452.648.151.435.295 – fucosidosis
MeSH C18.452.648.151.435.340 – glycogen storage disease type II
MeSH C18.452.648.151.435.590 – mucolipidoses
MeSH C18.452.648.151.435.810 – sialic acid storage disease
MeSH C18.452.648.151.435.825 – sphingolipidoses
MeSH C18.452.648.151.435.825.200 – Fabry disease
MeSH C18.452.648.151.435.825.300 – gangliosidoses
MeSH C18.452.648.151.435.825.300.300 – gangliosidoses GM2
MeSH C18.452.648.151.435.825.300.300.800 – Sandhoff disease
MeSH C18.452.648.151.435.825.300.300.840 – Tay–Sachs disease
MeSH C18.452.648.151.435.825.300.300.920 – Tay–Sachs disease, AB variant
MeSH C18.452.648.151.435.825.300.400 – gangliosidosis gm1
MeSH C18.452.648.151.435.825.400 – Gaucher disease
MeSH C18.452.648.151.435.825.590 – leukodystrophy, globoid cell
MeSH C18.452.648.151.435.825.594 – leukodystrophy, metachromatic
MeSH C18.452.648.151.435.825.700 – Niemann–Pick diseases
MeSH C18.452.648.151.445 – maple syrup urine disease
MeSH C18.452.648.151.447 – MELAS syndrome
MeSH C18.452.648.151.450 – menkes kinky hair syndrome
MeSH C18.452.648.151.505 – MERRF syndrome
MeSH C18.452.648.151.580 – mucolipidoses
MeSH C18.452.648.151.640 – oculocerebrorenal syndrome
MeSH C18.452.648.151.650 – ornithine carbamoyltransferase deficiency disease
MeSH C18.452.648.151.680 – peroxisomal disorders
MeSH C18.452.648.151.680.100 – adrenoleukodystrophy
MeSH C18.452.648.151.680.760 – refsum disease
MeSH C18.452.648.151.680.970 – Zellweger syndrome
MeSH C18.452.648.151.687 – phenylketonurias
MeSH C18.452.648.151.687.500 – phenylketonuria, maternal
MeSH C18.452.648.151.725 – pyruvate carboxylase deficiency disease
MeSH C18.452.648.151.750 – pyruvate dehydrogenase complex deficiency disease
MeSH C18.452.648.151.825 – sphingolipidoses
MeSH C18.452.648.151.825.200 – Fabry disease
MeSH C18.452.648.151.825.300 – gangliosidoses
MeSH C18.452.648.151.825.300.300 – gangliosidoses gm2
MeSH C18.452.648.151.825.300.300.700 – Sandhoff disease
MeSH C18.452.648.151.825.300.300.850 – Tay–Sachs disease
MeSH C18.452.648.151.825.300.300.925 – Tay–Sachs disease, AB variant
MeSH C18.452.648.151.825.300.400 – gangliosidosis gm1
MeSH C18.452.648.151.825.400 – Gaucher disease
MeSH C18.452.648.151.825.590 – leukodystrophy, globoid cell
MeSH C18.452.648.151.825.594 – leukodystrophy, metachromatic
MeSH C18.452.648.151.825.700 – Niemann–Pick diseases
MeSH C18.452.648.151.875 – tyrosinemias
MeSH C18.452.648.202 – carbohydrate metabolism, inborn errors
MeSH C18.452.648.202.125 – carbohydrate-deficient glycoprotein syndrome
MeSH C18.452.648.202.251 – fructose metabolism, inborn errors
MeSH C18.452.648.202.251.221 – fructose-1,6-diphosphatase deficiency
MeSH C18.452.648.202.251.271 – Hereditary fructose intolerance
MeSH C18.452.648.202.303 – fucosidosis
MeSH C18.452.648.202.355 – galactosemias
MeSH C18.452.648.202.449 – glycogen storage disease
MeSH C18.452.648.202.449.448 – glycogen storage disease type I
MeSH C18.452.648.202.449.500 – glycogen storage disease type II
MeSH C18.452.648.202.449.510 – glycogen storage disease type IIb
MeSH C18.452.648.202.449.520 – glycogen storage disease type III
MeSH C18.452.648.202.449.540 – glycogen storage disease type IV
MeSH C18.452.648.202.449.560 – glycogen storage disease type V
MeSH C18.452.648.202.449.580 – glycogen storage disease type VI
MeSH C18.452.648.202.449.600 – glycogen storage disease type VII
MeSH C18.452.648.202.449.620 – glycogen storage disease type VIII
MeSH C18.452.648.202.460 – hyperoxaluria, primary
MeSH C18.452.648.202.589 – lactose intolerance
MeSH C18.452.648.202.607 – mannosidase deficiency diseases
MeSH C18.452.648.202.607.500 – alpha-mannosidosis
MeSH C18.452.648.202.607.750 – beta-mannosidosis
MeSH C18.452.648.202.670 – mucolipidoses
MeSH C18.452.648.202.715 – mucopolysaccharidoses
MeSH C18.452.648.202.715.640 – mucopolysaccharidosis I
MeSH C18.452.648.202.715.645 – mucopolysaccharidosis II
MeSH C18.452.648.202.715.650 – mucopolysaccharidosis III
MeSH C18.452.648.202.715.655 – mucopolysaccharidosis IV
MeSH C18.452.648.202.715.670 – mucopolysaccharidosis VI
MeSH C18.452.648.202.715.675 – mucopolysaccharidosis VII
MeSH C18.452.648.202.720 – multiple carboxylase deficiency
MeSH C18.452.648.202.720.100 – biotinidase deficiency
MeSH C18.452.648.202.720.380 – holocarboxylase synthetase deficiency
MeSH C18.452.648.202.810 – pyruvate metabolism, inborn errors
MeSH C18.452.648.202.810.444 – Leigh disease
MeSH C18.452.648.202.810.666 – pyruvate carboxylase deficiency disease
MeSH C18.452.648.202.810.766 – pyruvate dehydrogenase complex deficiency disease
MeSH C18.452.648.240 – cytochrome-c oxidase deficiency
MeSH C18.452.648.390 – glucosephosphate dehydrogenase deficiency
MeSH C18.452.648.437 – hyperbilirubinemia, hereditary
MeSH C18.452.648.437.281 – Crigler–Najjar syndrome
MeSH C18.452.648.437.528 – gilbert disease
MeSH C18.452.648.499 – jaundice, chronic idiopathic
MeSH C18.452.648.556 – lipid metabolism, inborn errors
MeSH C18.452.648.556.475 – hypercholesterolemia, familial
MeSH C18.452.648.556.480 – hyperlipidemia, familial combined
MeSH C18.452.648.556.480.390 – hypercholesterolemia, familial
MeSH C18.452.648.556.480.395 – hyperlipoproteinemia type IV
MeSH C18.452.648.556.484 – hyperlipoproteinemia type III
MeSH C18.452.648.556.490 – hyperlipoproteinemia type IV
MeSH C18.452.648.556.495 – hyperlipoproteinemia type V
MeSH C18.452.648.556.500 – hypolipoproteinemia
MeSH C18.452.648.556.500.220 – abetalipoproteinemia
MeSH C18.452.648.556.500.440 – hypobetalipoproteinemia
MeSH C18.452.648.556.500.448 – lecithin acyltransferase deficiency
MeSH C18.452.648.556.500.724 – Tangier disease
MeSH C18.452.648.556.641 – lipoidosis
MeSH C18.452.648.556.641.201 – cholesterol ester storage disease
MeSH C18.452.648.556.641.391 – lipoidproteinosis
MeSH C18.452.648.556.641.509 – neuronal ceroid lipofuscinosis
MeSH C18.452.648.556.641.643 – Refsum disease
MeSH C18.452.648.556.641.723 – Sjögren–Larsson syndrome
MeSH C18.452.648.556.641.803 – sphingolipidoses
MeSH C18.452.648.556.641.803.300 – Fabry disease
MeSH C18.452.648.556.641.803.350 – gangliosidoses
MeSH C18.452.648.556.641.803.350.300 – gangliosidoses GM2
MeSH C18.452.648.556.641.803.350.300.700 – Sandhoff disease
MeSH C18.452.648.556.641.803.350.300.850 – Tay–Sachs disease
MeSH C18.452.648.556.641.803.350.300.925 – Tay–Sachs disease, AB variant
MeSH C18.452.648.556.641.803.350.360 – gangliosidosis gm1
MeSH C18.452.648.556.641.803.441 – Gaucher disease
MeSH C18.452.648.556.641.803.585 – leukodystrophy, globoid cell
MeSH C18.452.648.556.641.803.594 – leukodystrophy, metachromatic
MeSH C18.452.648.556.641.803.730 – Niemann–Pick diseases
MeSH C18.452.648.556.641.803.850 – sea-blue histiocyte syndrome
MeSH C18.452.648.556.641.923 – Wolman disease
MeSH C18.452.648.556.645 – lipoprotein lipase deficiency, familial
MeSH C18.452.648.556.750 – peroxisomal disorders
MeSH C18.452.648.556.750.025 – acatalasia
MeSH C18.452.648.556.750.112 – adrenoleukodystrophy
MeSH C18.452.648.556.750.200 – chondrodysplasia punctata, rhizomelic
MeSH C18.452.648.556.750.760 – Refsum disease
MeSH C18.452.648.556.750.970 – Zellweger syndrome
MeSH C18.452.648.556.850 – Smith–Lemli–Opitz syndrome
MeSH C18.452.648.556.925 – xanthomatosis, cerebrotendinous
MeSH C18.452.648.595 – lysosomal storage diseases
MeSH C18.452.648.595.201 – cholesterol ester storage disease
MeSH C18.452.648.595.554 – lysosomal storage diseases, nervous system
MeSH C18.452.648.595.554.295 – fucosidosis
MeSH C18.452.648.595.554.340 – glycogen storage disease type II
MeSH C18.452.648.595.554.590 – mucolipidoses
MeSH C18.452.648.595.554.810 – sialic acid storage disease
MeSH C18.452.648.595.554.825 – sphingolipidoses
MeSH C18.452.648.595.554.825.200 – Fabry disease
MeSH C18.452.648.595.554.825.300 – gangliosidoses
MeSH C18.452.648.595.554.825.300.300 – gangliosidoses GM2
MeSH C18.452.648.595.554.825.300.300.800 – Sandhoff disease
MeSH C18.452.648.595.554.825.300.300.840 – Tay–Sachs disease
MeSH C18.452.648.595.554.825.300.300.920 – Tay–Sachs disease, AB variant
MeSH C18.452.648.595.554.825.300.400 – gangliosidosis gm1
MeSH C18.452.648.595.554.825.400 – Gaucher disease
MeSH C18.452.648.595.554.825.590 – leukodystrophy, globoid cell
MeSH C18.452.648.595.554.825.594 – leukodystrophy, metachromatic
MeSH C18.452.648.595.554.825.700 – Niemann–Pick diseases
MeSH C18.452.648.595.577 – mannosidase deficiency diseases
MeSH C18.452.648.595.577.500 – alpha-mannosidosis
MeSH C18.452.648.595.577.750 – beta-mannosidosis
MeSH C18.452.648.595.600 – mucopolysaccharidoses
MeSH C18.452.648.595.600.640 – mucopolysaccharidosis I
MeSH C18.452.648.595.600.645 – mucopolysaccharidosis II
MeSH C18.452.648.595.600.650 – mucopolysaccharidosis III
MeSH C18.452.648.595.600.655 – mucopolysaccharidosis IV
MeSH C18.452.648.595.600.670 – mucopolysaccharidosis VI
MeSH C18.452.648.595.600.675 – mucopolysaccharidosis VII
MeSH C18.452.648.595.803 – sphingolipidoses
MeSH C18.452.648.595.803.300 – Fabry disease
MeSH C18.452.648.595.803.350 – gangliosidoses
MeSH C18.452.648.595.803.350.300 – gangliosidoses GM2
MeSH C18.452.648.595.803.350.300.700 – Sandhoff disease
MeSH C18.452.648.595.803.350.300.850 – Tay–Sachs disease
MeSH C18.452.648.595.803.350.300.925 – Tay–Sachs disease, AB variant
MeSH C18.452.648.595.803.441 – Gaucher disease
MeSH C18.452.648.595.803.585 – leukodystrophy, globoid cell
MeSH C18.452.648.595.803.594 – leukodystrophy, metachromatic
MeSH C18.452.648.595.803.730 – Niemann–Pick diseases
MeSH C18.452.648.595.803.850 – sea-blue histiocyte syndrome
MeSH C18.452.648.595.923 – Wolman disease
MeSH C18.452.648.618 – metal metabolism, inborn errors
MeSH C18.452.648.618.337 – hemochromatosis
MeSH C18.452.648.618.403 – hepatolenticular degeneration
MeSH C18.452.648.618.482 – hypophosphatasia
MeSH C18.452.648.618.544 – hypophosphatemia, familial
MeSH C18.452.648.618.590 – Menkes kinky hair syndrome
MeSH C18.452.648.618.711 – paralyses, familial periodic
MeSH C18.452.648.618.711.550 – hypokalemic periodic paralysis
MeSH C18.452.648.618.711.600 – paralysis, hyperkalemic periodic
MeSH C18.452.648.618.815 – pseudohypoparathyroidism
MeSH C18.452.648.618.815.815 – pseudopseudohypoparathyroidism
MeSH C18.452.648.730 – porphyria, erythropoietic
MeSH C18.452.648.735 – porphyrias, hepatic
MeSH C18.452.648.735.074 – coproporphyria, hereditary
MeSH C18.452.648.735.150 – porphyria, acute intermittent
MeSH C18.452.648.735.250 – porphyria cutanea tarda
MeSH C18.452.648.735.437 – porphyria, hepatoerythropoietic
MeSH C18.452.648.735.625 – porphyria, variegate
MeSH C18.452.648.735.812 – protoporphyria, erythropoietic
MeSH C18.452.648.769 – progeria
MeSH C18.452.648.798 – purine–pyrimidine metabolism, inborn errors
MeSH C18.452.648.798.368 – gout
MeSH C18.452.648.798.368.410 – arthritis, gouty
MeSH C18.452.648.798.594 – Lesch–Nyhan syndrome
MeSH C18.452.648.851 – renal tubular transport, inborn errors
MeSH C18.452.648.851.093 – acidosis, renal tubular
MeSH C18.452.648.851.191 – aminoaciduria, renal
MeSH C18.452.648.851.191.250 – cystinuria
MeSH C18.452.648.851.191.457 – Hartnup disease
MeSH C18.452.648.851.368 – cystinosis
MeSH C18.452.648.851.368.210 – Fanconi syndrome
MeSH C18.452.648.851.532 – glycosuria, renal
MeSH C18.452.648.851.647 – hypophosphatemia, familial
MeSH C18.452.648.851.750 – oculocerebrorenal syndrome
MeSH C18.452.648.851.770 – pseudohypoaldosteronism
MeSH C18.452.648.925 – steroid metabolism, inborn errors
MeSH C18.452.648.925.249 – adrenal hyperplasia, congenital
MeSH C18.452.648.925.500 – mineralocorticoid excess syndrome, apparent
MeSH C18.452.648.925.750 – ichthyosis, x-linked
MeSH C18.452.648.925.875 – Smith–Lemli–Opitz syndrome

MeSH C18.452.660 – mitochondrial diseases[edit]

MeSH C18.452.730 – ochronosis[edit]

MeSH C18.452.750 – phosphorus metabolism disorders[edit]

MeSH C18.452.872 – skin diseases, metabolic[edit]

MeSH C18.452.940 – wasting syndrome[edit]

MeSH C18.452.950 – water-electrolyte imbalance[edit]

MeSH C18.654 – nutrition disorders[edit]

MeSH C18.654.180 – child nutrition disorders[edit]

MeSH C18.654.422 – infant nutrition disorders[edit]

MeSH C18.654.521 – malnutrition[edit]

MeSH C18.654.726 – overnutrition[edit]

MeSH C18.654.940 – wasting syndrome[edit]

The list continues at List of MeSH codes (C19).